Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoporosis]

R Ziegler1

  • 1Medizinische Universitätsklinik und Poliklinik, Abteilung Innere Medizin I (Endokrinologie und Stoffwechsel), Heidelberg.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|September 20, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated and manual assays for urinary crosslinks of collagen: which assay to use?

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·1998
Same author

Glucocorticoid-induced osteoporosis: prevention and treatment.

Steroids·1998
Same author

[Biphosphonate therapy in the management of skeletal metastases].

Der Orthopade·1998
Same author

Mammalian fauna and biostratigraphy of the pre-Neandertal site of Reilingen, Germany.

Journal of human evolution·1998
Same author

On the phylogenetic position of the pre-Neandertal specimen from Reilingen, Germany.

Journal of human evolution·1998
Same author

[Endocrinology].

Der Internist·1998
Same journal

[In Process Citation]

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1999
Same journal

[A case from practice (306). Erythema (chronicum) migrans (stage I of Lyme borreliosis].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[A case from practice (305). Recurrent erysipelas--tinea pedis et unginum--chronic venous insufficiency].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Neuroendocrine tumors of the stomach (stomach carcinoid)].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Mental suffering IN patients with parkinsonism].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
See all related articles

Liver cirrhosis can cause bone loss, including osteoporosis, due to impaired nutrient absorption and direct toxic effects. While vitamin D deficiency is rare, preventing other risk factors is key for bone health.

Area of Science:

  • Hepatology
  • Endocrinology
  • Bone Metabolism

Context:

  • Liver cirrhosis is frequently associated with metabolic bone diseases like osteoporosis and osteomalacia.
  • Normal liver function is crucial for calcium and vitamin D absorption and metabolism.
  • Alcoholic liver disease and primary biliary cirrhosis are specific conditions linked to bone abnormalities.

Purpose:

  • To explore the relationship between liver cirrhosis and bone pathologies.
  • To investigate the mechanisms contributing to bone loss in cirrhosis, including nutrient deficiencies, hormonal imbalances, and direct toxic effects.
  • To review current understanding and potential therapeutic strategies for hepatic osteopenia.

Summary:

  • Liver cirrhosis can lead to osteoporosis and osteomalacia, primarily through impaired nutrient absorption and direct toxic effects of substances like bile salts on osteoblasts.

Related Experiment Videos

  • While severe vitamin D deficiency is uncommon, hypogonadism exacerbates bone loss. Alcoholic liver disease and primary biliary cirrhosis share a pattern of normal resorption but decreased bone formation.
  • Bone loss persists even after liver transplantation due to immunosuppressive therapy. Preventive measures focus on optimizing calcium and vitamin D intake, managing hypogonadism, and avoiding immobility.

    • Impact:

    • Highlights the complex interplay between liver health and skeletal integrity.
    • Underscores the need for proactive bone management in patients with liver cirrhosis.
    • Suggests potential therapeutic avenues, including fluoride therapy and cautious use of antiresorptive agents, for post-transplant bone loss.